key: cord-0841893-7cw5di9z
authors: Baratto, Claudia; Caravita, Sergio; Parati, Gianfranco
title: Heart failure with preserved ejection fraction and COVID‐19: which comes first, the chicken or the egg? Letter regarding the article ‘Heart failure with preserved ejection fraction according to the HFA‐PEFF score in COVID‐19 patients: clinical correlates and echocardiographic findings’
date: 2021-06-28
journal: Eur J Heart Fail
DOI: 10.1002/ejhf.2273
sha: 2c395a704a350d1e481fcad3a66b5a1c5ce3f7ae
doc_id: 841893
cord_uid: 7cw5di9z

nan

We have read with extreme interest the paper 'Heart Failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings' by Hadzibegovic et al. 1 By applying non-invasive scores to 64 patients hospitalized for COVID-19 in the general ward, Hadzibegovic et al. could highlight a relevant proportion of individuals at intermediate or high risk for heart failure with preserved ejection fraction (HFpEF). 1 Based on their findings, the authors suggest that diastolic dysfunction could have been directly triggered by COVID-19-related myocardial damage, as suggested by the correlation between troponin release and the probability of HFpEF assessed through the scores. 1 The authors should be commended for the effort of obtaining echocardiographic and clinical data in hospitalized COVID-19 patients, linking COVID-19 with HFpEF manifestations.

However, these observations could be interpreted also in a different perspective, based on our previous reports on the invasive haemodynamic characteristics of 21 mechanically-ventilated COVID-19 patients. 2 Firstly, our cohort admitted to the intensive care unit and burdened by severe COVID-19 was invariably characterized by a high-output state with surprisingly low pulmonary vascular resistance, likely favoured by the hyperinflammatory milieu triggered by SARS-CoV-2 and the vascular tropism of this virus. 2 increases, also pulmonary artery pressure increases, losing its capability to reflect left heart filling pressure. Accordingly, we might suggest a word of caution on the use of the HFA-PEFF and H 2 FPEF score in COVID-19 patients, given that these scores have been derived or validated in a completely different outpatient setting, and both incorporate a flow-uncorrected echocardiographic estimate of pulmonary artery systolic pressure as a surrogate for left ventricular filling pressure. Indeed, in 25% of our COVID-19 patients assessed in the intensive care unit, pulmonary hypertension was simply a reflection of high cardiac output, coupled with normal pulmonary artery wedge pressure. 2 Similarly, we could recently show in 18 patients survived from COVID-19 that the pressure-flow relationship of the pulmonary circulation is upward and rightward shifted even at the time of their hospital discharge, 3 suggesting that the hyperdynamic state that characterize SARS-CoV-2 infection may last for quite a long time, contributing to increase pulmonary artery pressure without necessarily implying high left ventricular filling pressure.

Secondly, in the majority of our severely compromised patients admitted to the intensive care unit, high cardiac output was associated with post-capillary pulmonary hypertension. 2 This finding points to a peculiar and poorly understood HFpEF haemodynamic phenotype, i.e. a high-output heart failure, 4 which might present with different characteristics from the contemporary paradigm interpreting HFpEF as a condition characterized by a steep rise in pulmonary artery wedge pressure as cardiac output increases during exercise. 5 Furthermore, the high prevalence of post-capillary pulmonary hypertension we found in COVID-19 patients 2 was somehow uncoupled with the pre-test probability of HFpEF based on the H 2 FPEF score: the proportion of patients at high/intermediate/low risk for HFpEF in our cohort was 0%/66%/34%, respectively.

Thus, we believe that our results, obtained with right heart catheterization in mechanically-ventilated COVID-19 patients admitted to the intensive care unit, 2 of its pathophysiology, as we have previously shown, this link can be extremely detrimental, since high left ventricular filling pressure might have an additional negative impact on an already decreased lung compliance, favouring a vicious circle between the heart and the lung. 2 Whether the association between HFpEF and COVID-19 is related to direct cardiac damage by SARS-CoV-2, or rather favoured by a high-output state in predisposed individuals with underlying left ventricular diastolic dysfunction, this is an aspect that deserves further research.

Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings

Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization

Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study

High-output heart failure: a 15

Current limitations of invasive exercise hemodynamics for the diagnosis of heart failure with preserved ejection fraction

Dr Caravita received the grant Vera Srebot from the Fondazione CNR/Regione Toscana per la Ricerca Medica e di Sanità Pubblica. Dr Baratto is the recipient of a research grant from the European Society of Cardiology.